Article
Single Pass Mean Residence Time in Peripheral Tissues: A Distribution Parameter Intrinsic to the Tissue Affinity of a Drug

https://doi.org/10.1002/jps.2600751202Get rights and content

Abstract

The single pass mean residence time in peripheral tissues, t¯p1, is a characteristic constant of linear pharmacokinetic systems and nonlinear systems with linear distribution kinetics. It is descriptive of distribution kinetics in such systems and is not dependent on elimination kinetics as are other related parameters, e.g., mean residence time in peripheral tissues, t¯p. Equations are derived which permit estimation of t¯p1, from experimental data for systems in which no peripheral elimination occurs. The type of data required are systemic drug levels resulting from iv administration. The probability density function for single pass residence time in peripheral tissues is derived. It is shown that t¯p1, is related to the amount of drug in the peripheral tissues at steady state according to (Ap)ss=CLdCsst¯p1, where CLd is the distribution clearance, and Css is the steady-state systemic drug level. Values of t¯p1, are presented for several drugs.

References and Notes (41)

  • M. Chung

    J. Pharm. Sci.

    (1984)
  • D. Perrier et al.

    J. Pharm. Sci.

    (1982)
  • P. Veng-Pedersen et al.

    J. Pharm. Sci.

    (1985)
  • G.B. Park et al.

    J. Pharm. Sci.

    (1983)
  • M. Rowland et al.

    J. Pharm. Sci.

    (1968)
  • S.A. Kaplan et al.

    J. Pharm. Sci.

    (1973)
  • P.G. Welling et al.

    J. Pharm. Sci.

    (1978)
  • M. Rowland et al.

    J. Pharm. Sci.

    (1968)
  • D.J. Greenblatt et al.

    J. Pharm. Sci.

    (1979)
  • D.J. Greenblatt et al.

    J. Pharm. Sci.

    (1982)
  • C.V. Manion et al.

    J. Pharm. Sci.

    (1977)
  • K. Yamaoka et al.

    J. Pharmacokinet. Biopharm.

    (1978)
  • S. Riegelman et al.

    J. Pharmacokinet. Biopharm.

    (1980)
  • D.J. Cutler

    J. Pharm. Pharmacol.

    (1978)
  • Linear disposition is here defined in the general sense that the systemic drug level follows the superposition...
  • P. Veng-Pedersen

    J. Pharmacokinet. Biopharm.

    (1984)
  • W.R. Gillespie et al.

    J. Pharmacokinet. Biopharm.

    (1985)
  • P. Veng-Pedersen et al.

    J. Pharmacokinet. Biopharm.

    (1984)
  • P. Veng-Pedersen

    J. Pharmacokinet. Biopharm.

    (1980)
  • Caution: the specific inferences discussed herein are based on cross-study comparisons. The differences and...
  • Cited by (0)

    View full text